{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:20:38Z","timestamp":1790000438467,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFD0501505"],"award-info":[{"award-number":["2016YFD0501505"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010203","name":"Agriculture Research System of China","doi-asserted-by":"crossref","award":["CARS-35"],"award-info":[{"award-number":["CARS-35"]}],"id":[{"id":"10.13039\/501100010203","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Central Public Interest Scientific Institution Basal Research Fund","award":["Y2016CG23"],"award-info":[{"award-number":["Y2016CG23"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31602095"],"award-info":[{"award-number":["31602095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00253-019-09691-5","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T10:59:35Z","timestamp":1554375575000},"page":"3367-3379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin"],"prefix":"10.1007","volume":"103","author":[{"given":"Baofeng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"issue":"8","key":"9691_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","volume":"31","author":"KM Asadi","year":"2013","unstructured":"Asadi KM, Oloomi M, Mahdavi M, Habibi M, Bouzari S (2013) Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 31(8):1210\u20131216. https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.059","journal-title":"Vaccine"},{"issue":"12","key":"9691_CR2","doi-asserted-by":"publisher","first-page":"e82217","DOI":"10.1371\/journal.pone.0082217","volume":"8","author":"O Aziz-Boaron","year":"2013","unstructured":"Aziz-Boaron O, Leibovitz K, Gelman B, Kedmi M, Klement E (2013) Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine. PLoS One 8(12):e82217. https:\/\/doi.org\/10.1371\/journal.pone.0082217","journal-title":"PLoS One"},{"issue":"48","key":"9691_CR3","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1016\/j.vaccine.2008.08.070","volume":"26","author":"DY Bargieri","year":"2008","unstructured":"Bargieri DY, Rosa DS, Braga CJ, Carvalho BO, Costa FT, Espindola NM, Vaz AJ, Soares IS, Ferreira LC, Rodrigues MM (2008) New malaria vaccine candidates based on the Plasmodium vivax merozoite surface protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. Vaccine 26(48):6132\u20136142. https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.070","journal-title":"Vaccine"},{"issue":"11\u201312","key":"9691_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0264-410X(01)00503-5","volume":"20","author":"PV Barnett","year":"2002","unstructured":"Barnett PV, Carabin H (2002) A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20(11\u201312):1505\u20131514","journal-title":"Vaccine"},{"issue":"5869","key":"9691_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/298030a0","volume":"298","author":"JL Bittle","year":"1982","unstructured":"Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298(5869):30\u201333","journal-title":"Nature"},{"issue":"2","key":"9691_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0264-410X(88)80024-0","volume":"6","author":"F Brown","year":"1988","unstructured":"Brown F (1988) Use of peptides for immunization against foot-and-mouth disease. Vaccine 6(2):180\u2013182","journal-title":"Vaccine"},{"issue":"19","key":"9691_CR7","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1128\/JVI.00577-06","volume":"80","author":"A Burman","year":"2006","unstructured":"Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T (2006) Specificity of the VP1 GH loop of foot-and-mouth disease virus for alphav integrins. J Virol 80(19):9798\u20139810. https:\/\/doi.org\/10.1128\/JVI.00577-06","journal-title":"J Virol"},{"issue":"2","key":"9691_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.antiviral.2011.08.006","volume":"92","author":"AV Capozzo","year":"2011","unstructured":"Capozzo AV, Wilda M, Bucafusco D, de Los ALM, Franco-Mahecha OL, Mansilla FC, Perez-Filgueira DM, Grigera PR (2011) Vesicular stomatitis virus glycoprotein G carrying a tandem dimer of foot and mouth disease virus antigenic site a can be used as DNA and peptide vaccine for cattle. Antivir Res 92(2):219\u2013227. https:\/\/doi.org\/10.1016\/j.antiviral.2011.08.006","journal-title":"Antivir Res"},{"issue":"19","key":"9691_CR9","doi-asserted-by":"publisher","first-page":"195101","DOI":"10.1088\/0957-4484\/21\/19\/195101","volume":"21","author":"YS Chen","year":"2010","unstructured":"Chen YS, Hung YC, Lin WH, Huang GS (2010) Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology 21(19):195101. https:\/\/doi.org\/10.1088\/0957-4484\/21\/19\/195101","journal-title":"Nanotechnology"},{"issue":"4","key":"9691_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14760584.2018.1457443","volume":"17","author":"B Cui","year":"2018","unstructured":"Cui B, Liu X, Fang Y, Zhou P, Zhang Y, Wang Y (2018) Flagellin as a vaccine adjuvant. Expert Rev Vaccines 17(4):335\u2013349. https:\/\/doi.org\/10.1080\/14760584.2018.1457443","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"9691_CR11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1128\/JVI.01480-07","volume":"82","author":"D Dicara","year":"2008","unstructured":"Dicara D, Burman A, Clark S, Berryman S, Howard MJ, Hart IR, Marshall JF, Jackson T (2008) Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol 82(3):1537\u20131546. https:\/\/doi.org\/10.1128\/JVI.01480-07","journal-title":"J Virol"},{"issue":"5","key":"9691_CR12","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/JVI.64.5.2260-2264.1990","volume":"64","author":"TR Doel","year":"1990","unstructured":"Doel TR, Gale C, Do AC, Mulcahy G, Dimarchi R (1990) Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J Virol 64(5):2260\u20132264","journal-title":"J Virol"},{"issue":"3","key":"9691_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.antiviral.2008.11.005","volume":"81","author":"D Dory","year":"2009","unstructured":"Dory D, Remond M, Beven V, Cariolet R, Backovic M, Zientara S, Jestin A (2009) Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs. Antivir Res 81(3):217\u2013225. https:\/\/doi.org\/10.1016\/j.antiviral.2008.11.005","journal-title":"Antivir Res"},{"issue":"1","key":"9691_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jviromet.2007.12.018","volume":"149","author":"Y Du","year":"2008","unstructured":"Du Y, Li Y, He H, Qi J, Jiang W, Wang X, Tang B, Cao J, Wang X, Jiang P (2008) Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine. J Virol Methods 149(1):144\u2013152. https:\/\/doi.org\/10.1016\/j.jviromet.2007.12.018","journal-title":"J Virol Methods"},{"issue":"50","key":"9691_CR15","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1016\/j.vaccine.2005.07.043","volume":"23","author":"WT Golde","year":"2005","unstructured":"Golde WT, Pacheco JM, Duque H, Doel T, Penfold B, Ferman GS, Gregg DR, Rodriguez LL (2005) Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23(50):5775\u20135782. https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.043","journal-title":"Vaccine"},{"issue":"2","key":"9691_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","volume":"17","author":"MJ Grubman","year":"2004","unstructured":"Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17(2):465\u2013493","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"9691_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","volume":"74","author":"AN Honko","year":"2006","unstructured":"Honko AN, Sriranganathan N, Lees CJ, Mizel SB (2006) Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 74(2):1113\u20131120. https:\/\/doi.org\/10.1128\/IAI.74.2.1113-1120.2006","journal-title":"Infect Immun"},{"issue":"4","key":"9691_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","volume":"25","author":"JW Huleatt","year":"2007","unstructured":"Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ (2007) Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25(4):763\u2013775. https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.013","journal-title":"Vaccine"},{"issue":"2","key":"9691_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","volume":"26","author":"JW Huleatt","year":"2008","unstructured":"Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ (2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26(2):201\u2013214. https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.062","journal-title":"Vaccine"},{"key":"9691_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2017.08.014","volume":"210","author":"ME Khalifa","year":"2017","unstructured":"Khalifa ME, El-Deeb AH, Zeidan SM, Hussein HA, Abu-El-Naga HI (2017) Enhanced protection against FMDV in cattle after prime-boost vaccination based on mucosal and inactivated FMD vaccine. Vet Microbiol 210:1\u20137. https:\/\/doi.org\/10.1016\/j.vetmic.2017.08.014","journal-title":"Vet Microbiol"},{"issue":"1","key":"9691_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.virol.2012.11.001","volume":"436","author":"P Lawrence","year":"2013","unstructured":"Lawrence P, Pacheco JM, Uddowla S, Hollister J, Kotecha A, Fry E, Rieder E (2013) Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis. Virology 436(1):150\u2013161. https:\/\/doi.org\/10.1016\/j.virol.2012.11.001","journal-title":"Virology"},{"issue":"2","key":"9691_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.virol.2004.07.025","volume":"328","author":"G Li","year":"2004","unstructured":"Li G, Chen W, Yan W, Zhao K, Liu M, Zhang J, Fei L, Xu Q, Sheng Z, Lu Y, Zheng Z (2004) Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes. Virology 328(2):274\u2013281. https:\/\/doi.org\/10.1016\/j.virol.2004.07.025","journal-title":"Virology"},{"issue":"21","key":"9691_CR23","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.1007\/s00253-017-8523-y","volume":"101","author":"K Li","year":"2017","unstructured":"Li K, Bao H, Wei G, Li D, Chen Y, Fu Y, Cao Y, Li P, Sun P, Bai X, Ma X, Zhang J, Lu Z, Liu Z (2017) Molecular vaccine prepared by fusion of XCL1 to the multi-epitope protein of foot-and-mouth disease virus enhances the specific humoural immune response in cattle. Appl Microbiol Biotechnol 101(21):7889\u20137900. https:\/\/doi.org\/10.1007\/s00253-017-8523-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"9691_CR24","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1007\/s00253-017-8246-0","volume":"101","author":"X Liu","year":"2017","unstructured":"Liu X, Fang Y, Zhou P, Lu Y, Zhang Q, Xiao S, Dong Z, Pan L, Lv J, Zhang Z, Zhang Y, Wang Y (2017) Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. Appl Microbiol Biotechnol 101(12):4905\u20134914. https:\/\/doi.org\/10.1007\/s00253-017-8246-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"9691_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.smim.2009.05.005","volume":"21","author":"S Manicassamy","year":"2009","unstructured":"Manicassamy S, Pulendran B (2009) Modulation of adaptive immunity with Toll-like receptors. Semin Immunol 21(4):185\u2013193. https:\/\/doi.org\/10.1016\/j.smim.2009.05.005","journal-title":"Semin Immunol"},{"issue":"11","key":"9691_CR26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1086\/517613","volume":"195","author":"WF McDonald","year":"2007","unstructured":"McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ (2007) A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 195(11):1607\u20131617. https:\/\/doi.org\/10.1086\/517613","journal-title":"J Infect Dis"},{"issue":"Pt 2","key":"9691_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1099\/0022-1317-67-2-289","volume":"67","author":"RH Meloen","year":"1986","unstructured":"Meloen RH, Barteling SJ (1986) An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection. J Gen Virol 67(Pt 2):289\u2013294. https:\/\/doi.org\/10.1099\/0022-1317-67-2-289.","journal-title":"J Gen Virol"},{"issue":"12","key":"9691_CR28","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.4049\/jimmunol.170.12.6217","volume":"170","author":"SB Mizel","year":"2003","unstructured":"Mizel SB, Honko AN, Moors MA, Smith PS, West AP (2003) Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5\/Toll-like receptor 4 complexes. J Immunol 170(12):6217\u20136223","journal-title":"J Immunol"},{"issue":"1","key":"9691_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2460\/ajvr.1990.51.01.40","volume":"51","author":"DO Morgan","year":"1990","unstructured":"Morgan DO, Moore DM (1990) Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am J Vet Res 51(1):40\u201345","journal-title":"Am J Vet Res"},{"issue":"7","key":"9691_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1586\/14760584.2013.811185","volume":"12","author":"A Mount","year":"2013","unstructured":"Mount A, Koernig S, Silva A, Drane D, Maraskovsky E, Morelli AB (2013) Combination of adjuvants: the future of vaccine design. Expert Rev Vaccines 12(7):733\u2013746. https:\/\/doi.org\/10.1586\/14760584.2013.811185","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"9691_CR31","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.4049\/jimmunol.1090134","volume":"186","author":"JP Pandey","year":"2011","unstructured":"Pandey JP (2011) Comment on \u201cFlagellin as an adjuvant: cellular mechanisms and potential\u201d. J Immunol 186(3):1299; author reply 1299. https:\/\/doi.org\/10.4049\/jimmunol.1090134","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"9691_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/tbed.12521","volume":"63","author":"L Robinson","year":"2016","unstructured":"Robinson L, Knight-Jones TJ, Charleston B, Rodriguez LL, Gay CG, Sumption KJ, Vosloo W (2016) Global foot-and-mouth disease research update and gap analysis: 3\u2014vaccines. Transbound Emerg Dis 63(Suppl 1):30\u201341. https:\/\/doi.org\/10.1111\/tbed.12521.","journal-title":"Transbound Emerg Dis"},{"issue":"Suppl 4","key":"9691_CR33","doi-asserted-by":"publisher","first-page":"D90","DOI":"10.1016\/j.vaccine.2009.08.039","volume":"27","author":"LL Rodriguez","year":"2009","unstructured":"Rodriguez LL, Grubman MJ (2009) Foot and mouth disease virus vaccines. Vaccine 27(Suppl 4):D90\u2013D94. https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.039.","journal-title":"Vaccine"},{"issue":"3","key":"9691_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12250-011-3174-0","volume":"26","author":"JJ Shao","year":"2011","unstructured":"Shao JJ, Wang JF, Chang HY, Liu JX (2011) Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep. Virol Sin 26(3):190\u2013197. https:\/\/doi.org\/10.1007\/s12250-011-3174-0","journal-title":"Virol Sin"},{"issue":"5","key":"9691_CR35","doi-asserted-by":"publisher","first-page":"e2257","DOI":"10.1371\/journal.pone.0002257","volume":"3","author":"L Song","year":"2008","unstructured":"Song L, Nakaar V, Kavita U, Price A, Huleatt J, Tang J, Jacobs A, Liu G, Huang Y, Desai P, Maksymiuk G, Takahashi V, Umlauf S, Reiserova L, Bell R, Li H, Zhang Y, McDonald WF, Powell TJ, Tussey L (2008) Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs. PLoS One 3(5):e2257. https:\/\/doi.org\/10.1371\/journal.pone.0002257","journal-title":"PLoS One"},{"issue":"17","key":"9691_CR36","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","volume":"29","author":"F Steinhagen","year":"2011","unstructured":"Steinhagen F, Kinjo T, Bode C, Klinman DM (2011) TLR-based immune adjuvants. Vaccine 29(17):3341\u20133355. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.002","journal-title":"Vaccine"},{"issue":"39","key":"9691_CR37","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1016\/j.vaccine.2012.06.086","volume":"30","author":"DN Taylor","year":"2012","unstructured":"Taylor DN, Treanor JJ, Sheldon EA, Johnson C, Umlauf S, Song L, Kavita U, Liu G, Tussey L, Ozer K, Hofstaetter T, Shaw A (2012) Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine 30(39):5761\u20135769. https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.086","journal-title":"Vaccine"},{"issue":"11","key":"9691_CR38","doi-asserted-by":"publisher","first-page":"e27605","DOI":"10.1371\/journal.pone.0027605","volume":"6","author":"G Wang","year":"2011","unstructured":"Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, Lu J, Zhou P, Fang Y, Jiang S (2011) Intranasal delivery of cationic PLGA nano\/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge. PLoS One 6(11):e27605. https:\/\/doi.org\/10.1371\/journal.pone.0027605","journal-title":"PLoS One"},{"issue":"35","key":"9691_CR39","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1016\/j.vaccine.2014.06.060","volume":"32","author":"X Wen","year":"2014","unstructured":"Wen X, Wen K, Cao D, Li G, Jones RW, Li J, Szu S, Hoshino Y, Yuan L (2014) Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus DeltaVP8* subunit parenteral vaccines. Vaccine 32(35):4420\u20134427. https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.060","journal-title":"Vaccine"},{"issue":"6070","key":"9691_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1126\/science.1215584","volume":"335","author":"SI Yoon","year":"2012","unstructured":"Yoon SI, Kurnasov O, Natarajan V, Hong M, Gudkov AV, Osterman AL, Wilson IA (2012) Structural basis of TLR5-flagellin recognition and signaling. Science 335(6070):859\u2013864. https:\/\/doi.org\/10.1126\/science.1215584","journal-title":"Science"},{"issue":"2","key":"9691_CR41","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1006\/viro.1995.1519","volume":"212","author":"P Zamorano","year":"1995","unstructured":"Zamorano P, Wigdorovitz A, Perez-Filgueira M, Carrillo C, Escribano JM, Sadir AM, Borca MV (1995) A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Virology 212(2):614\u2013621. https:\/\/doi.org\/10.1006\/viro.1995.1519","journal-title":"Virology"},{"issue":"4","key":"9691_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01900.x","volume":"65","author":"YL Zhang","year":"2007","unstructured":"Zhang YL, Guo YJ, Wang KY, Lu K, Li K, Zhu Y, Sun SH (2007) Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 65(4):320\u2013328. https:\/\/doi.org\/10.1111\/j.1365-3083.2007.01900.x","journal-title":"Scand J Immunol"},{"issue":"6","key":"9691_CR43","doi-asserted-by":"publisher","first-page":"e0129617","DOI":"10.1371\/journal.pone.0129617","volume":"10","author":"C Zhang","year":"2015","unstructured":"Zhang C, Zhu S, Wei L, Yan X, Wang J, Quan R, She R, Hu F, Liu J (2015) Recombinant flagellin-porcine circovirus type 2 cap fusion protein promotes protective immune responses in mice. PLoS One 10(6):e0129617. https:\/\/doi.org\/10.1371\/journal.pone.0129617","journal-title":"PLoS One"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-019-09691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-019-09691-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-019-09691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T16:21:18Z","timestamp":1721146878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-019-09691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["9691"],"URL":"https:\/\/doi.org\/10.1007\/s00253-019-09691-5","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All guinea pig experiments were performed in a biosafety level 3 laboratory at the Lanzhou Veterinary Research Institute (LVRI) at the Chinese Academy of Agricultural Sciences (CAAS). This study was approved by the Institutional Animal Use and Care Committee of the CAAS. All guinea pigs used in the present study were humanely bred during the experiments and were euthanized at the end of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}